Effect Neonatal Ketamine Treatment on Exploratory and Anxiety-like Behaviours in Adulthood
K. Akillioglu, M. Karadepe
Clinical Psychopharmacology and Neuroscience February 28, 2021 DOI: 10.9758/cpn.2021.19.1.93 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Controlled experimental animal study Peer reviewed |
|---|---|
| Population | Male Balb/c and C57BL/6 mice exposed to ketamine on postnatal day 7 and tested in adulthood |
| Intervention | Ketamine |
| Dose | single dose 10 or 20 mg/kg; repeated doses 10 or 20 mg/kg every 240 minutes, three times |
| Topics | Anxiety Esketamine Ketamine |
| Key findings | In C57BL/6 mice, single and repeated 20 mg/kg neonatal ketamine doses and repeated 10 mg/kg doses increased anxiety-like behaviour and decreased exploratory behaviour in the elevated plus maze and open field, while Balb/c mice showed no significant behavioural effects at any dose. The authors conclude that hereditary factors may influence the behavioural response to neonatal ketamine. |
Abstract
Objective: In this study, we evaluated the effect of neonatal ketamine exposure on anxiety-like and exploratory behaviours in adult the Balb/c and C57BL/6 strains of mice which anxiety responses are different.
Methods: Ketamine was administered at two different doses single dose (10, 20 mg/kg, 0.1 ml/10 g body weight, intraperitoneally) and repeated doses (10, 20 mg/kg every 240 minutes; thrice times) on the 7th postnatal day to male Balb/c and C57BL/6 mice. In adulthood, open-field (OF) and elevated plus maze (EPM) apparatuses were used to evaluate exploratory and anxiety-like behaviour.
Results: In the C57BL/6 mice, the 20 mg/kg single dose decreased open-arm time and total-arm entries in EPM and increased time of central latency and decreased distance travelled in OF. Both the 10 and 20 mg/kg repetitive doses increased time of central latency and decreased time spent in the centre, frequency of rearing and centre crossing in OF and decreased open-arm time, total-arm entries, number of open-arm entries in EPM. The 20 mg/kg repetitive dose decreased number of head dipping behaviours in EPM. In the Balb/c mice, both the single and repetitive 10−20 mg/kg doses had no significant effect on anxiety-like and exploratory behaviours.
Conclusion: There were no significant differences in anxiety-like and exploratory behaviour in different strains by the single 10 mg/kg dose. However, in the C57BL/6 mice, both the single and repetitive 20 mg/kg doses and the 10 mg/kg repetitive dose increased anxiety-like behaviour and decreased exploratory behaviour in EPM and OF. In conclusion, hereditary factors may be effective on the effect of neonatal ketamine treatment on anxiety-like and exploratory behaviour.
Comparable studies
Other preclinical and animal studies on ketamine for anxiety, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression Rats | 2020 | Preclinical study | |
| Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats Wistar rats | 2018 | Experimental study | n = 40 |
| Repeated Dosing of Ketamine in the Forced Swim Test: Are Multiple Shots Better Than One? Rodents | 2021 | Review | |
| Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents Rodents | 2024 | Review | |
| Sexually Dimorphic Behavioral Profile in a Transgenic Model Enabling Targeted Recombination in Active Neurons in Response to Ketamine and (2R,6R)-Hydroxynorketamine Administration Arc-CreERT2 × CAG-Sun1/sfGFP mice | 2020 | Experimental study |
Citations in the library
Cited by 3
- Repeated 7-day exposure to ketamine induces anxiety-like behaviors and neuronal apoptosis in mice via DRD1-medicated inhibition of Akt/Gsk-3β phosphorylation. Cell Biology and Toxicology January 30, 2026
- Ketamine’s rapid antidepressant effects are mediated by Ca2+-permeable AMPA receptors bioRxiv January 16, 2023
- Effects of the Recurrent and Different Doses of Ketamine Exposure on Anxiety-like Behaviors and Locomotor Activity in Juvenile Rats Current Alzheimer Research December 1, 2022
Cites 3
- Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans Archives of General Psychiatry March 1, 1994
- Mechanisms of Ketamine Action as an Antidepressant Molecular Psychiatry March 13, 2018
- Repeated ketamine treatment induces sex-specific behavioral and neurochemical effects in mice. Behavioural Brain Research October 1, 2016